{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:37:24Z","timestamp":1778863044166,"version":"3.51.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"9731","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/s0140-6736(10)60393-5","type":"journal-article","created":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T11:59:03Z","timestamp":1274356743000},"page":"2110-2119","source":"Crossref","is-referenced-by-count":216,"title":["New vaccines for tuberculosis"],"prefix":"10.1016","volume":"375","author":[{"given":"Stefan HE","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul-Henri","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/S0140-6736(10)60393-5_bib1","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/nm1221","article-title":"Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis","volume":"11","author":"Kaufmann","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/S0140-6736(10)60393-5_bib2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1920","article-title":"Envisioning future strategies for vaccination against tuberculosis","volume":"6","author":"Kaufmann","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.it.2005.09.012","article-title":"Recent findings in immunology give tuberculosis vaccines a new boost","volume":"26","author":"Kaufmann","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2006.02.013","article-title":"The development and impact of tuberculosis vaccines","volume":"124","author":"Young","year":"2006","journal-title":"Cell"},{"key":"10.1016\/S0140-6736(10)60393-5_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/path.1906","article-title":"New insights into the function of granulomas in human tuberculosis","volume":"208","author":"Ulrichs","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib6","series-title":"Prophylactic vaccination against tuberculosis using \u201cBCG\u201d","author":"Calmette","year":"1927"},{"key":"10.1016\/S0140-6736(10)60393-5_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ni0708-705","article-title":"Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff","volume":"9","author":"Kaufmann","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrmicro1688","article-title":"The contribution of immunology to the rational design of novel antibacterial vaccines","volume":"5","author":"Kaufmann","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10875-007-9087-x","article-title":"Toll or toll-free adjuvant path toward the optimal vaccine development","volume":"27","author":"Ishii","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrmicro1538","article-title":"Who puts the tubercle in tuberculosis?","volume":"5","author":"Russell","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib12","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.cell.2007.05.059","article-title":"M tuberculosis and M leprae translocate from the phagolysosome to the cytosol in myeloid cells","volume":"129","author":"van der Wel","year":"2007","journal-title":"Cell"},{"key":"10.1016\/S0140-6736(10)60393-5_bib13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10495-005-2940-6","article-title":"No life without death-apoptosis as prerequisite for T cell activation","volume":"10","author":"Winau","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/S0140-6736(10)60393-5_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol Today"},{"key":"10.1016\/S0140-6736(10)60393-5_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.coi.2009.07.004","article-title":"Fine-tuning of T cell responses during infection","volume":"21","author":"Dorhoi","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/S0140-6736(10)60393-5_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4(+) T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.immunol.021908.132723","article-title":"Regulatory T cells in the control of host-microorganism interactions (*)","volume":"27","author":"Belkaid","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0140-6736(10)60393-5_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.immunol.25.022106.141548","article-title":"Effector and memory CTL differentiation","volume":"25","author":"Williams","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.0105-2896.2006.00400.x","article-title":"Th1 memory: implications for vaccine development","volume":"211","author":"Foulds","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/S0140-6736(10)60393-5_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.it.2006.03.007","article-title":"T-cell homing specificity and plasticity: new concepts and future challenges","volume":"27","author":"Mora","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib26","first-page":"1331","article-title":"Bacille Calmette-Guerin vaccine-related disease in HIV-infected children: a systematic review","volume":"13","author":"Azzopardi","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S0140-6736(10)60393-5_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/S0140-6736(10)60393-5_bib28","first-page":"193","article-title":"Revised BCG vaccination guidelines for infants at risk for HIV infection","volume":"82","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/S0140-6736(10)60393-5_bib29","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.vaccine.2007.06.045","article-title":"BCG and HIV reconsidered: moving the research agenda forward","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/S0140-6736(10)60393-5_bib30","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1086\/597304","article-title":"HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guerin vaccine","volume":"199","author":"Mansoor","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/S0140-6736(10)60393-5_bib31","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(10)60393-5_bib32","series-title":"The new plagues: pandemics and poverty in a globalized world","author":"Kaufmann","year":"2009"},{"key":"10.1016\/S0140-6736(10)60393-5_bib33","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/clinids\/20.4.982","article-title":"Geographic latitude and the efficacy of bacillus Calmette-Guerin vaccine","volume":"20","author":"Wilson","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0140-6736(10)60393-5_bib34","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2249.2006.03222.x","article-title":"The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guerin vaccination in southern England and northern Malawi","volume":"146","author":"Weir","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib35","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1016\/j.vaccine.2009.05.021","article-title":"The potential impact of helminth infection on trials of novel tuberculosis vaccines","volume":"27","author":"Hatherill","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/S0140-6736(10)60393-5_bib37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"Betts","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.20030205","article-title":"Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program","volume":"198","author":"Voskuil","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/S0140-6736(10)60393-5_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.micro.55.1.139","article-title":"Nonreplicating persistence of Mycobacterium tuberculosis","volume":"55","author":"Wayne","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib40","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/IAI.00434-08","article-title":"A replication-limited recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG","volume":"76","author":"Tullius","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/S0140-6736(10)60393-5_bib41","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Gu\u00e9rin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/S0140-6736(10)60393-5_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.immuni.2005.12.001","article-title":"Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis","volume":"24","author":"Winau","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/S0140-6736(10)60393-5_bib43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature07781","article-title":"Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation","volume":"458","author":"Torchinsky","year":"2009","journal-title":"Nature"},{"key":"10.1016\/S0140-6736(10)60393-5_bib44","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/S0140-6736(10)60393-5_bib45","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"Verreck","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/S0140-6736(10)60393-5_bib46","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.vaccine.2006.05.097","article-title":"Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis","volume":"24","author":"Sambandamurthy","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/S0140-6736(10)60393-5_bib47","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1586\/14760584.6.5.741","article-title":"IC31 and IC30, novel types of vaccine adjuvant based on peptide delivery systems","volume":"6","author":"Lingnau","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/S0140-6736(10)60393-5_bib48","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/icb.2009.14","article-title":"TB vaccines: current status and future perspectives","volume":"87","author":"Aagaard","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib50","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B\u2013ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in na\u00efve human volunteers","volume":"28","author":"van Dissel","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/S0140-6736(10)60393-5_bib51","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","article-title":"Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy","volume":"174","author":"Dietrich","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/hv.8570","article-title":"The candidate tuberculosis vaccine Mtb72F\/AS02A: tolerability and immunogenicity in humans","volume":"5","author":"Von Eschen","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/S0140-6736(10)60393-5_bib53","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/S0140-6736(10)60393-5_bib54","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/rccm.200809-1486OC","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals","volume":"179","author":"Sander","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S0140-6736(10)60393-5_bib55","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/JVI.62.5.1530-1534.1988","article-title":"Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination","volume":"62","author":"Rooney","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib56","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon","volume":"75","author":"Radosevic","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/S0140-6736(10)60393-5_bib57","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/S0140-6736(10)60393-5_bib58","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2005.08.101","article-title":"Development of nonhuman adenoviruses as vaccine vectors","volume":"24","author":"Bangari","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/S0140-6736(10)60393-5_bib59","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.184.3.993","article-title":"Identification of a heparin-binding hemagglutinin present in mycobacteria","volume":"184","author":"Menozzi","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0140-6736(10)60393-5_bib60","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of M tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S0140-6736(10)60393-5_bib61","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.micinf.2009.07.005","article-title":"Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis","volume":"11","author":"Rouanet","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1016\/S0140-6736(10)60393-5_bib62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tube.2006.01.016","article-title":"Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis","volume":"86","author":"Locht","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/S0140-6736(10)60393-5_bib63","first-page":"239","article-title":"The Koch phenomenon and the immunopathology of tuberculosis","volume":"215","author":"Rook","year":"1996","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/S0140-6736(10)60393-5_bib64","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.rmed.2005.09.026","article-title":"Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis","volume":"100","author":"Dlugovitzky","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/S0140-6736(10)60393-5_bib65","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2741\/1292","article-title":"Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis","volume":"9","author":"Stanford","year":"2004","journal-title":"Front Biosci"},{"key":"10.1016\/S0140-6736(10)60393-5_bib66","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille Calmette-Gu\u00e9rin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine","volume":"24","author":"Von Reyn","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/S0140-6736(10)60393-5_bib67","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tube.2006.01.024","article-title":"RUTI: a new chance to shorten the treatment of latent tuberculosis infection","volume":"86","author":"Cardona","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/S0140-6736(10)60393-5_bib68","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.vaccine.2009.09.134","article-title":"Double-blind, randomized, placebo-controlled phase I clinical trial of the therapeutical antituberculous vaccine RUTI","volume":"28","author":"Vilaplana","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/S0140-6736(10)60393-5_bib69","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1515\/BC.2008.057","article-title":"Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection","volume":"389","author":"Lin","year":"2008","journal-title":"Biol Chem"},{"key":"10.1016\/S0140-6736(10)60393-5_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(10)60359-5","article-title":"Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice","author":"Wallis","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(10)60393-5_bib71","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drudis.2009.10.005","article-title":"The quest for biomarkers in tuberculosis","volume":"15","author":"Parida","year":"2010","journal-title":"Drug Discov Today"},{"key":"10.1016\/S0140-6736(10)60393-5_bib73","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1371\/journal.pmed.0040252","article-title":"Development of new tuberculosis vaccines: a global perspective on regulatory issues","volume":"4","author":"Brennan","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/S0140-6736(10)60393-5_bib74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1472-6939-9-15","article-title":"Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting","volume":"9","author":"Minnies","year":"2008","journal-title":"BMC Med Ethics"},{"key":"10.1016\/S0140-6736(10)60393-5_bib75","series-title":"Tuberculosis research and development: 2009 report on tuberculosis research funding trends, 2005\u20132008","year":"2009"},{"key":"10.1016\/S0140-6736(10)60393-5_bib76","series-title":"Neglected disease research and development: how much are we really spending?","author":"Moran","year":"2008"},{"key":"10.1016\/S0140-6736(10)60393-5_bib77","series-title":"A critical analysis of funding trends 2005\u20132007: an update","author":"Agarwal","year":"2009"},{"key":"10.1016\/S0140-6736(10)60393-5_bib78","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm0307-299","article-title":"Changing funding patterns in tuberculosis","volume":"13","author":"Kaufmann","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/S0140-6736(10)60393-5_bib80","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1098\/rsif.2007.1138","article-title":"Eliminating human tuberculosis in the twenty-first century","volume":"5","author":"Dye","year":"2008","journal-title":"J R Soc Interface"},{"key":"10.1016\/S0140-6736(10)60393-5_bib81","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"Abu-Raddad","year":"2009","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673610603935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673610603935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T21:53:41Z","timestamp":1591307621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673610603935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":78,"journal-issue":{"issue":"9731","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0140673610603935"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(10)60393-5","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}